Literature DB >> 3487578

Suppressive effect of cyclosporin A on the development of Leishmania tropica-induced lesions in genetically susceptible BALB/c mice.

W Solbach, K Forberg, E Kammerer, C Bogdan, M Röllinghoff.   

Abstract

The effect of cyclosporin A (CyA) application on the development of cutaneous lesions was analyzed in genetically susceptible BALB/c mice infected s.c. with Leishmania tropica promastigotes. Daily i.p. injections of CyA, beginning 2 days before or at the day of the infection, dose dependently inhibited the development of parasite-induced lesions; no effect on the lesions was observed, however, if CyA application was started 14 days after the infection. Cessation of CyA administration after having successfully suppressed the cutaneous lesions for a period of 42 days, resulted in the development of lesions within 3 days. CyA had no inhibitory effect on lesions developing in L. tropica infected hypothymic BALB/c nu/nu mice. CyA or CyA-containing mouse serum did not directly affect the viability and the growth rate of L. tropica promastigotes, suggesting that the effect of the agent was imposed on the cells participating in the formation of the cutaneous lesions. Quantitative analysis of the cell distribution in the spleens of infected mice revealed that CyA markedly suppressed the infection-associated numerical increase of splenocytes. Within the Thy-1+ lymphocyte compartment, CyA had its most pronounced effect on the Lyt-1+ T lymphocyte subset. Early in the disease, the frequency of splenic cells proliferating in response to L. tropica antigen in vitro was clearly inhibited by CyA; in the later stages of the infection, however, this effect could not be observed, indicating the presence of L. tropica-inducible T cells being relatively resistant to CyA. Taken together, our findings indicate that CyA reversibly inhibits or delays the parasite-induced expansion of Lyt-1+ splenic T lymphocytes, and thus suppresses the biological function of those T cells that are instrumental for the formation of cutaneous lesions in L. tropica-infected BALB/c mice.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3487578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Infection of neutrophil granulocytes with Leishmania major activates ERK 1/2 and modulates multiple apoptotic pathways to inhibit apoptosis.

Authors:  Arup Sarkar; Eresso Aga; Uta Bussmeyer; Asima Bhattacharyya; Sonja Möller; Lars Hellberg; Martina Behnen; Werner Solbach; Tamás Laskay
Journal:  Med Microbiol Immunol       Date:  2012-06-03       Impact factor: 3.402

2.  Leishmania-infected macrophages are targets of NK cell-derived cytokines but not of NK cell cytotoxicity.

Authors:  Chittappen K Prajeeth; Simone Haeberlein; Heidi Sebald; Ulrike Schleicher; Christian Bogdan
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

3.  Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin 3 production in experimental murine cutaneous leishmaniasis.

Authors:  F Y Liew; S Millott; R Lelchuk; S Cobbold; H Waldmann
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

4.  Myeloid Cell-Derived HIF-1α Promotes Control of Leishmania major.

Authors:  Valentin Schatz; Yannic Strüssmann; Alexander Mahnke; Gunnar Schley; Maximilian Waldner; Uwe Ritter; Jens Wild; Carsten Willam; Nathalie Dehne; Bernhard Brüne; Jennifer M McNiff; Oscar R Colegio; Christian Bogdan; Jonathan Jantsch
Journal:  J Immunol       Date:  2016-10-17       Impact factor: 5.422

5.  Polyclonal B-cell stimulation by L3T4+ T cells in experimental leishmaniasis.

Authors:  M Lohoff; C Matzner; M Röllinghoff
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

6.  Cyclosporin A enhances elimination of intracellular L. major parasites by murine macrophages.

Authors:  C Bogdan; H Streck; M Röllinghoff; W Solbach
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

7.  Leishmania major parasites express cyclophilin isoforms with an unusual interaction with calcineurin.

Authors:  C Rascher; A Pahl; A Pecht; K Brune; W Solbach; H Bang
Journal:  Biochem J       Date:  1998-09-15       Impact factor: 3.857

8.  Cyclosporin A treatment of Leishmania donovani reveals stage-specific functions of cyclophilins in parasite proliferation and viability.

Authors:  Wai-Lok Yau; Thierry Blisnick; Jean-François Taly; Manuela Helmer-Citterich; Cordelia Schiene-Fischer; Olivier Leclercq; Jing Li; Dirk Schmidt-Arras; Miguel A Morales; Cedric Notredame; Daniel Romo; Philippe Bastin; Gerald F Späth
Journal:  PLoS Negl Trop Dis       Date:  2010-06-29

9.  Differential production of macrophage inflammatory protein 1gamma (MIP-1gamma), lymphotactin, and MIP-2 by CD4(+) Th subsets polarized in vitro and in vivo.

Authors:  Kerstin Müller; Susanne Bischof; Frank Sommer; Michael Lohoff; Werner Solbach; Tamás Laskay
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Cyclosporin A inhibits the growth of Cryptococcus neoformans in a murine model.

Authors:  C H Mody; G B Toews; M F Lipscomb
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.